PL1610817T3 - Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek - Google Patents

Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek

Info

Publication number
PL1610817T3
PL1610817T3 PL04716603T PL04716603T PL1610817T3 PL 1610817 T3 PL1610817 T3 PL 1610817T3 PL 04716603 T PL04716603 T PL 04716603T PL 04716603 T PL04716603 T PL 04716603T PL 1610817 T3 PL1610817 T3 PL 1610817T3
Authority
PL
Poland
Prior art keywords
infectious bronchitis
ibv
altered
bronchitis virus
spike gene
Prior art date
Application number
PL04716603T
Other languages
English (en)
Inventor
David Cavanagh
Paul Britton
Ian Tarpey
Original Assignee
Intervet Int Bv
Inst For Animal Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Inst For Animal Health filed Critical Intervet Int Bv
Publication of PL1610817T3 publication Critical patent/PL1610817T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL04716603T 2003-03-03 2004-03-03 Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek PL1610817T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03075623 2003-03-03
EP04716603A EP1610817B1 (en) 2003-03-03 2004-03-03 Infectious bronchitis virus with an altered spike gene
PCT/EP2004/050247 WO2004078203A2 (en) 2003-03-03 2004-03-03 Infectious bronchitis virus with an altered spike gene

Publications (1)

Publication Number Publication Date
PL1610817T3 true PL1610817T3 (pl) 2010-05-31

Family

ID=32946897

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04716603T PL1610817T3 (pl) 2003-03-03 2004-03-03 Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek

Country Status (11)

Country Link
US (1) US7445785B2 (pl)
EP (1) EP1610817B1 (pl)
AT (1) ATE445412T1 (pl)
BR (1) BRPI0407948B1 (pl)
DE (1) DE602004023594D1 (pl)
DK (1) DK1610817T3 (pl)
ES (1) ES2333223T3 (pl)
PL (1) PL1610817T3 (pl)
PT (1) PT1610817E (pl)
SI (1) SI1610817T1 (pl)
WO (1) WO2004078203A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
KR101092977B1 (ko) 2009-03-09 2011-12-26 대한민국 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신
GB0911794D0 (en) 2009-07-07 2009-08-19 Animal Health Inst Chimaeric protein
US20140141043A1 (en) * 2012-11-16 2014-05-22 Auburn University Compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
GB201308057D0 (en) 2013-05-03 2013-06-12 Pirbright Inst The Protein
GB201413020D0 (en) 2014-07-23 2014-09-03 Pribright The Inst Coronavirus
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus
CN110433288A (zh) * 2018-05-03 2019-11-12 乐斯福公司 试剂盒和β-葡聚糖提取物在禽类动物免疫增强中的应用
EA202191145A1 (ru) * 2018-10-31 2021-08-23 Бёрингер Ингельхайм Ветмедика Гмбх Вакцина виб 4/91 с гетерологичным шиповидным белком
EP3873515A1 (en) 2018-10-31 2021-09-08 Boehringer Ingelheim Vetmedica GmbH H52 ibv vaccine with heterologous spike protein
CN110819599B (zh) * 2019-11-22 2023-05-19 华南农业大学 一种预防台湾型传染性支气管炎的疫苗株
CA3198118A1 (en) 2020-11-12 2022-05-19 Martijn Alexander LANGEREIS Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049195A1 (en) * 1997-04-29 1998-11-05 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
ATE463253T1 (de) 2000-02-29 2010-04-15 Wyeth Llc In ovo schutz gegen infektiöse bronchitis
BR0209837A (pt) * 2001-05-17 2004-12-14 Univ Utrecht Partìcula semelhante a vìrus isolada ou recombimante capaz de replicação, composição, e, método para inibir ou bloquear uma infecção com um coronavìrus ou partìcula semelhante a coronavìrus

Also Published As

Publication number Publication date
DK1610817T3 (da) 2010-01-25
SI1610817T1 (sl) 2010-01-29
PT1610817E (pt) 2010-01-18
ES2333223T3 (es) 2010-02-18
WO2004078203A2 (en) 2004-09-16
WO2004078203A9 (en) 2005-08-25
US20070154489A1 (en) 2007-07-05
EP1610817A2 (en) 2006-01-04
DE602004023594D1 (de) 2009-11-26
ATE445412T1 (de) 2009-10-15
BRPI0407948B1 (pt) 2014-10-21
EP1610817B1 (en) 2009-10-14
US7445785B2 (en) 2008-11-04
WO2004078203A3 (en) 2004-11-25
BRPI0407948A (pt) 2006-03-07

Similar Documents

Publication Publication Date Title
MXPA05009580A (es) Vacuna contra el virus de la influenza.
PT1610817E (pt) Vírus da bronquite infecciosa com um gene da espícula alterado
HK1207828A1 (en) Cell-derived viral vaccines with low levels of residual cell dna dna
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
CA2448208A1 (en) Influenza vaccine composition
UA85536C2 (en) Viral antigens
MX2022003435A (es) Desarrollo de una vacuna novedosa atenuada viva contra la peste porcina africana basada en la eliminacion del gen i177l.
NZ597182A (en) Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2018140766A3 (en) Porcine coronavirus vaccines
AU2003278729A8 (en) Regulated bacterial lysis for gene vaccine vector delivery and antigen release
WO2011106607A3 (en) Subunit vaccines for herpes viruses and methods of use
WO2002087494A3 (en) Novel vaccine
PH12017500216A1 (en) Vaccine in serotype-9 fowl adenovirus recombinant vector
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
PH12014502085B1 (en) Modified marek`s disease virus, and vaccines made therefrom
MX2023002969A (es) Mejora de la inmunidad usando un ligando quimerico del cumulo de diferenciacion 40 (cd40) y vacuna contra el coronavirus.
GB2409681A (en) Nucleic acid constructs for gene expression
HU0102823D0 (en) A broad spectrum infectious bursal disease virus vaccine
MX2023003651A (es) Virus de la diarrea epidemica porcina atenuado.
MXPA06010616A (es) Composiciones vacunales obtenidas a partir de streptomyces.
KR20180084336A (ko) 마우스에 대한 병원성이 증가된 인플루엔자 a 바이러스